Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
OS Therapies Incorporated ( (OSTX) ) has shared an update.
On June 26, 2025, OS Therapies Incorporated completed a second closing of its warrant exercise inducement and exchange offer. This involved agreements with holders of existing warrants to purchase shares of the company’s common stock, with the company issuing new warrants in return. The new warrants are exercisable immediately and have a five-year term, with an exercise price of $3.00 per share. The second closing brought in approximately $616,000 in gross proceeds for the company, which plans to file a resale registration statement for the new warrant shares.
The most recent analyst rating on (OSTX) stock is a Buy with a $8.00 price target. To see the full list of analyst forecasts on OS Therapies Incorporated stock, see the OSTX Stock Forecast page.
Spark’s Take on OSTX Stock
According to Spark, TipRanks’ AI Analyst, OSTX is a Underperform.
OS Therapies Incorporated faces significant financial difficulties, marked by increasing net losses, negative cash flows, and reliance on external financing. The technical analysis indicates bearish momentum with the stock trading below its moving averages. Valuation is challenging with no earnings to support a P/E ratio or dividend yield. These factors contribute to a low overall stock score, reflecting the company’s financial instability and negative market sentiment.
To see Spark’s full report on OSTX stock, click here.
More about OS Therapies Incorporated
Average Trading Volume: 302,497
Technical Sentiment Signal: Strong Sell
Learn more about OSTX stock on TipRanks’ Stock Analysis page.